Thus far, the effect of tirzepatide on cardiovascular risk factors has indicated improvements in lipids, lipoprotein profiles, glucose control, body weight, blood pressure, and several biomarkers of inflammation in adults with overweight or obesity both with and without T2D (Tables 1, 2, 3, 4)
Other potential changes include alterations in cardiovascular risk factors
In addition, Zepbound comes in a vial format, where you draw the medication yourself, or the KwikPen , a multi-dose monthly injection pen that has all four doses that you need for the month
For a deeper understanding of how these doses translate when you are measuring with a syringe, check our tirzepatide dosage in units guide or the complete compound dosage chart